title: Effect of emulsions of medium and long chain triglyceride on human adipose tissue prostaglandin production in vitro.
abstract: Preliminary in vitro studies have been performed to assess the effect of experimental lipid emulsions of varying fatty acid composition on human adipose tissue metabolism. Subcutaneous human adipose tissue was obtained during elective surgery and placed in tissue culture. Physical mixtures of long chain triglyceride (LCT) and/or medium chain triglyceride (MCT) were added to the tissue culture medium so that the final concentration was 400 mg/dl. After a 3-day incubation period the tissue was harvested, placed in buffer and used to determine in vitro production of the prostaglandins prostacyclin I2 (measured as its stable endproduct 6-keto PGF1 alpha), thromboxane A2 (measured as TXB2), and prostaglandin E2. Measurements of the fatty acid profile found in the neutral- and phospholipid fraction of the adipose tissue and fat cell size were also made. The results demonstrate that samples incubated in 100% MCT had the most significant increase in prostaglandin production whereas those incubated in 100% LCT had the most significant decrease in activity of the three prostaglandins assayed, when compared to controls. The addition of LCT to MCT caused a dose-related decrease in adipose tissue prostaglandin production. There were no significant changes in the profile of fatty acids found in the neutral- or phospholipid fraction of adipose tissue. The results indicate that the relative level of MCT/LCT incubated with human adipose tissue has a significant effect on prostaglandin production.
authors.affiliation: Department of Pediatrics, Mt. Sinai School of Medicine, New York, NY 10029.
authors.forename: D P
authors.initials: DP
authors.lastname: Katz
authors.forename: J
authors.initials: J
authors.lastname: Rudick
authors.forename: J L
authors.initials: JL
authors.lastname: Knittle
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000096:biosynthesis; D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D015232:Dinoprostone; D005217:Fat Emulsions, Intravenous / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D011453:Prostaglandins / Q000096:biosynthesis*; D011458:Prostaglandins E / Q000096:biosynthesis; D013929:Thromboxane B2 / Q000096:biosynthesis; D014280:Triglycerides / Q000494:pharmacology*
chemical_list: D005217:Fat Emulsions, Intravenous; D011453:Prostaglandins; D011458:Prostaglandins E; D014280:Triglycerides; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D015232:Dinoprostone